Skin Implants Market Scope
Skin implants are a type of cosmetic surgery that involves the use of synthetic skin to replace lost or damaged skin. Skin implants are used in many different procedures, including breast augmentation and tummy tuck. The synthetic material is placed under the patient’s own skin, and can be made from silicone gel or poly-lactic acid (PLA). This means that it is not visible to others and does not need any incisions to be made in the body. The skin implant can be used for cosmetic purposes, such as breast augmentation or facial surgery. It can also be used for medical purposes, such as replacing lost bone tissue after cancer treatment or reconstructive surgery.
Attributes | Details |
---|
Study Period | 2018-2030 |
Base Year | 2023 |
Unit | Value (USD Million) |
Key Companies Profiled | Medtronic Plc. (Ireland), Johnson and Johnson (United States), Boston Scientific Corporation (United States), Biotronik (Germany), Livanova Plc (United Kingdom), Globus Medical, Inc. (United States), Nuvasive, Inc. (United States), Integra Lifesciences Holding Corporation (United States), Institut Straumann Ag (Switzerland), Conmed Corporation (United States), Abbott Laboratories (United States) and Smith & Nephew Plc (United Kingdom) |
CAGR | 7.5% |
The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. The global market is highly competitive and consists of a limited number of providers who compete with each other. The intense competition, changing consumer spending patterns, demographic trends, and frequent changes in consumer preferences pose significant opportunities for market growth. The key manufacturers are targeting the innovations of the products with better quality, better technical characteristics, and also assist in providing and humanizing the after-sale service to the consumers. The key players are probable to keep a stronghold on the market over the anticipated period. Research Analyst at AMA estimates that Global Players will contribute to the maximum growth of Global Skin Implants market throughout the predicted period.
Medtronic Plc. (Ireland), Johnson and Johnson (United States), Boston Scientific Corporation (United States), Biotronik (Germany), Livanova Plc (United Kingdom), Globus Medical, Inc. (United States), Nuvasive, Inc. (United States), Integra Lifesciences Holding Corporation (United States), Institut Straumann Ag (Switzerland), Conmed Corporation (United States), Abbott Laboratories (United States) and Smith & Nephew Plc (United Kingdom) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are C.R. Bard, Inc. (United States), Wright Medical Group N.V (United States), Stryker Corporation (United States), Dentsply Sirona Inc. (United States), Zimmer Biomet Holdings Inc. (United States) and Others.
About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from the total available market.
Segmentation Overview
The study have segmented the market of Global Skin Implants market by Type and Region with country level break-up.
On the basis of geography, the market of Skin Implants has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).
region held largest market share in the year 2023.
Market Leaders and their expansionary development strategies
In May 2022 Medtronic has announced the acquisition of Intersect Ent. Medtronic gains PROPEL and SINUVA, which are unique bio absorbable, steroid-eluting implants for sinus patients, as a result of this acquisition. Following endoscopic sinus surgery, PROPEL implants are inserted to maintain sinus patency and provide localised steroid delivery. SINUVA implants are intended for use in the doctor's office to treat nasal polyps in adult patients who have had ethmoid sinus surgery.
In February 2022 Abbott had announced the launch of World's First Implant of Dual-Chamber Leadless Pacemaker in Pivotal Trial. Abbott's investigational Aveir DR dual-chamber pacemaker is intended to produce synchronous, beat-by-beat pacing of the proper atrium and heart ventricle of the centre Proprietary implant-to-implant (i2i) device technology is employed for communication between two implanted leadless pacemakers to manage the centre rate Aveir DR is additionally specifically designed to be retrieved if therapy needs evolve.
Influencing Trend:
Product Innovation According To Customer Preferences
Market Growth Drivers:
Increasing Demand for Body Modification and Emergence of Skin Implant Technology
Challenges:
Lack of Skilled Professionals and High Cost of Implants and Products Required
Restraints:
High Risk of Infection and Side Effects of Skin Implant Surgery
Opportunities:
Rising opportunities in Emerging Economies
Key Target Audience
Raw Materials Suppliers, New Entrants/Investors, Hospitals, Cosmetic Industries and End-Use Industries